Q linea

Q linea Assets per Share

The Total Assets per Share of Q linea (QLINEA.ST) as of Nov 17, 2026 is 57.43 SEK. In the previous year, Total Assets per Share was 22.99 SEK — a change of 149.79% (higher).

Assets per Share

57.43SEK

YoY

149.79%

Last updated:

Total Assets per Share of Q linea is 2025 57.43 SEK. Total Assets per Share of Q linea was 2024 22.99 SEK. It decreases by 149.79% higher compared to the previous year.

The Q linea Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
83.75 SEK
Jan 1, 2019
58.17 SEK
Jan 1, 2020
64.04 SEK
Jan 1, 2021
72.49 SEK
Jan 1, 2022
32.22 SEK
Jan 1, 2023
36.04 SEK
Jan 1, 2024
22.99 SEK
Jan 1, 2025
57.43 SEK
The Q linea Assets per Share history
YEARAssets per ShareYoY
57.43SEK+149.79%
22.99SEK-36.20%
36.04SEK+11.86%
32.22SEK-55.56%
72.49SEK+13.20%
64.04SEK+10.10%
58.17SEK-30.55%
83.75SEK+2,830.20%
2.86SEK+9.11%
2.62SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Q linea Stock analysis

What does Q linea do? Q-linea AB develops and manufactures in-vitro diagnostic solutions for infectious diseases, focusing on antibiotic susceptibility testing. The company's core product, ASTar, is a fully-automated instrument that provides susceptibility profiles within three to six hours directly from positive blood cultures. This enables early targeted antibiotic administration for sepsis identification in hospital patients, primarily serving hospital laboratories. The firm measures bacteria's antimicrobial susceptibility using its own disposables, which are integral to the ASTar system's operation. Q-linea AB's revenue model is based on selling the ASTar instrument and its associated disposables to hospital laboratories. The company's product is specifically designed for sepsis identification in hospital settings, where rapid and accurate antibiotic susceptibility testing is critical. By providing a faster solution than traditional methods, Q-linea targets hospital labs seeking to improve patient outcomes in sepsis cases. The company operates as a holding company with a focus on developing and manufacturing IVD solutions. Its primary customers are hospital laboratories, which purchase the ASTar system and disposables to streamline their diagnostic processes. The firm's business model centers on the sale of both the instrument and the consumable disposables, creating recurring revenue streams from ongoing disposables usage. Q linea is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Q linea stock

Total Assets per Share of Q linea is 57.43 SEK in 2025.

Total Assets per Share of Q linea changed from 22.99 SEK to 57.43 SEK, representing a 149.79% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Q linea since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Q linea

All Key Metrics — Q linea